RA | ||||
N = 60 | ||||
Mean ± SD (range) | ||||
Disease duration (years) | 9.3 ± 7.1 (1–30) | |||
Number of tender joints | 6.6 ± 4.8 (2–28) | |||
Number of swollen joints | 3.1 ± 3.1 (0–16) | |||
Disease activity score (DAS-28) | 5.1 ± 1.3 (3–8) | |||
Larsen score | 14.4 ± 6.9 (5–40) | |||
RA | ||||
N = 60 | ||||
HB (g/dl) | Mean ± SD | 11.4 | ± 1.4 | |
WBCs (× 103 /mm3) | Mean ± SD | 7.6 | ± 2.4 | |
ESR (mm/1st h) | Mean ± SD | 48.9 | ± 30.7 | |
Platelets(× 103 /mm3) | Mean ± SD | 290 | ± 101.6 | |
Urea (mg/dl) | Mean ± SD | 30.3 | ± 3.7 | |
Creatinine (mg/dl) | Mean ± SD | 0.9 | ± 0.2 | |
CRP | Negative | N, % | 21 | 35.0% |
Positive | N, % | 39 | 65.0% | |
CRP titre (mg/l) | Mean ± SD | 18.8 | ± 21.2 | |
RF | Negative | N, % | 12 | 20.0% |
Positive | N, % | 48 | 80.0% | |
RF titre (IU/ml) | Mean ± SD | 71.2 | ± 50.7 | |
Anti-CCP-Abs | Negative | N, % | 7 | 11.7% |
Positive | N, % | 53 | 88.3% | |
Anti-CCP-Abs titre (U/ml) | Mean ± SD | 66.3 | ± 52.7 |